13D/13G Filings - Eventide Asset Management, LLC

Real time Form 13D and 13G transaction reports:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
  • Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Goto Prev, 0, 1, 2, 3, 4, Next
Reported
DateTime
Transaction
Date
Type Company
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev Report View
2022-02-14
12:00 pm
Purchase
2021-12-31 13G Sutro Biopharma, Inc.
STRO
Eventide Asset Management, LLC 2,708,975
5.900%
338,000increase
(+14.26%)
Filing
History
2022-02-14
11:57 am
Purchase
2021-12-31 13G Praxis Precision Medicines, Inc.
PRAX
Eventide Asset Management, LLC 254,040
8.500%
19,835increase
(+8.47%)
Filing
History
2022-02-14
11:55 am
Sale
2021-12-31 13G Pliant Therapeutics, Inc.
PLRX
Eventide Asset Management, LLC 42,499
0.100%
-2,795,626decrease
(-98.50%)
Filing
History
2022-02-14
11:53 am
Sale
2021-12-31 13G KalVista Pharmaceuticals, Inc.
KALV
Eventide Asset Management, LLC 138,821
0.600%
-1,541,179decrease
(-91.74%)
Filing
History
2022-02-14
11:50 am
Sale
2021-12-31 13G Kala Pharmaceuticals, Inc.
KALA
Eventide Asset Management, LLC 0
0.000%
-138,000decrease
(Position Closed)
Filing
History
2022-02-14
11:47 am
Purchase
2021-12-31 13G Freeline Therapeutics Holdings plc
FRLN
Eventide Asset Management, LLC 232,377
9.700%
66,667increase
(+40.23%)
Filing
History
2022-02-14
11:46 am
Purchase
2021-12-31 13G ESSA Pharma Inc.
EPIX
Eventide Asset Management, LLC 3,318,647
7.500%
983,479increase
(+42.12%)
Filing
History
2022-02-14
11:43 am
Sale
2021-12-31 13G Entasis Therapeutics Holdings Inc.
ETTX
Eventide Asset Management, LLC 590,602
1.200%
-288,939decrease
(-32.85%)
Filing
History
2022-02-14
11:41 am
Purchase
2021-12-31 13G Zymeworks Inc.
ZYME
Eventide Asset Management, LLC 2,819,135
6.100%
2,819,135increase
(New Position)
Filing
History
2022-02-14
11:39 am
Purchase
2021-12-31 13G Annexon, Inc.
ANNX
Eventide Asset Management, LLC 2,850,000
7.400%
845,384increase
(+42.17%)
Filing
History
2022-02-14
11:37 am
Purchase
2021-12-31 13G VectivBio Holding AG
VECT
Eventide Asset Management, LLC 2,339,044
6.700%
2,339,044increase
(New Position)
Filing
History
2022-02-14
11:35 am
Purchase
2021-12-31 13G Prometheus Biosciences, Inc.
RXDX
Eventide Asset Management, LLC 3,742,507
9.600%
3,742,507increase
(New Position)
Filing
History
2022-02-14
11:33 am
Purchase
2021-12-31 13G Cogent Biosciences, Inc.
COGT
Eventide Asset Management, LLC 3,514,909
8.800%
3,514,909increase
(New Position)
Filing
History
2022-02-10
4:18 pm
Purchase
2022-01-31 13G KnowBe4, Inc.
KNBE
Eventide Asset Management, LLC 4,177,983
10.100%
4,177,983increase
(New Position)
Filing
History
2021-02-12
4:19 pm
Purchase
2020-12-31 13G ESSA Pharma Inc.
EPIX
Eventide Asset Management, LLC 2,335,168
7.000%
324,999increase
(+16.17%)
Filing
History
2021-02-12
4:16 pm
Sale
2020-12-31 13G ARYA SCIENCES ACQUISITION CORP
ARYAU
Eventide Asset Management, LLC 0
0.000%
-800,000decrease
(Position Closed)
Filing
History
2021-02-12
4:15 pm
Sale
2020-12-31 13G Magenta Therapeutics, Inc.
MGTA
Eventide Asset Management, LLC 1,000,000
2.100%
-2,393,894decrease
(-70.54%)
Filing
History
2021-02-12
4:13 pm
Sale
2020-12-31 13G STEMLINE THERAPEUTICS INC
STML
Eventide Asset Management, LLC 0
0.000%
-4,160,608decrease
(Position Closed)
Filing
History
2021-02-12
4:13 pm
Purchase
2020-12-31 13G Vital Farms, Inc.
VITL
Eventide Asset Management, LLC 2,053,232
5.200%
2,053,232increase
(New Position)
Filing
History
2021-02-12
4:11 pm
Purchase
2020-12-31 13G Praxis Precision Medicines, Inc.
PRAX
Eventide Asset Management, LLC 234,205
9.200%
234,205increase
(New Position)
Filing
History
Goto Prev, 0, 1, 2, 3, 4, Next